W R Laster

1.4k total citations
42 papers, 957 citations indexed

About

W R Laster is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, W R Laster has authored 42 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in W R Laster's work include Synthesis and biological activity (4 papers), Computational Drug Discovery Methods (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). W R Laster is often cited by papers focused on Synthesis and biological activity (4 papers), Computational Drug Discovery Methods (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). W R Laster collaborates with scholars based in United States. W R Laster's co-authors include Daniel P. Griswold, F. M. Schabel, Robert F. Struck, Donald L. Hill, Thomas H. Corbett, Y. Fulmer Shealy, John A. Montgomery, R W Brockman, Frank M. Schabel and Howard E. Skipper and has published in prestigious journals such as Journal of the American Chemical Society, Cancer and Cancer Research.

In The Last Decade

W R Laster

37 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W R Laster United States	17	397	317	175	129	100	42	957
I Wodinsky United States	15	492 1.2×	331 1.0×	100 0.6×	97 0.8×	90 0.9×	69	979
Glynn P. Wheeler United States	20	725 1.8×	268 0.8×	285 1.6×	270 2.1×	88 0.9×	60	1.3k
K.R. Harrap United Kingdom	18	574 1.4×	523 1.6×	219 1.3×	81 0.6×	119 1.2×	31	1.2k
Montgomery Ja United States	11	282 0.7×	234 0.7×	73 0.4×	89 0.7×	86 0.9×	18	685
Franz A. Schmid United States	14	296 0.7×	167 0.5×	101 0.6×	50 0.4×	71 0.7×	53	669
Laster Wr United States	18	433 1.1×	574 1.8×	92 0.5×	125 1.0×	242 2.4×	28	1.2k
O. Michael Colvin United States	15	337 0.8×	197 0.6×	98 0.6×	73 0.6×	73 0.7×	23	790
Jurij Stekar Germany	14	400 1.0×	263 0.8×	102 0.6×	91 0.7×	80 0.8×	25	1.0k
Peter R. Twentyman United Kingdom	22	787 2.0×	884 2.8×	96 0.5×	107 0.8×	108 1.1×	48	1.5k
Wayne D. Klohs United States	16	456 1.1×	249 0.8×	135 0.8×	89 0.7×	59 0.6×	33	728

Countries citing papers authored by W R Laster

Since Specialization

Citations

This map shows the geographic impact of W R Laster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W R Laster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W R Laster more than expected).

Fields of papers citing papers by W R Laster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W R Laster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W R Laster. The network helps show where W R Laster may publish in the future.

Co-authorship network of co-authors of W R Laster

This figure shows the co-authorship network connecting the top 25 collaborators of W R Laster. A scholar is included among the top collaborators of W R Laster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W R Laster. W R Laster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Waud, William R., et al.. (1991). Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia. Cancer Chemotherapy and Pharmacology. 27(6). 456–463. 34 indexed citations

Wilkoff, Lee J., Elizabeth A. Dulmadge, W R Laster, & Daniel P. Griswold. (1989). Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-β-D-arabinofuranosylcytosine. Cancer Chemotherapy and Pharmacology. 23(3). 145–150. 11 indexed citations

Harrison, Steadman D., et al.. (1987). Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo. Investigational New Drugs. 5(4). 345–351. 11 indexed citations

Schabel, Frank M., Daniel P. Griswold, Thomas H. Corbett, & W R Laster. (1984). Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology. Cancer. 54(S1). 1160–1167. 66 indexed citations

Shealy, Y. Fulmer, Charles A. Krauth, & W R Laster. (1984). 2-Chloroethyl (methylsulfonyl)methanesulfonate and related (methylsulfonyl)methanesulfonates. Antineoplastic activity in vivo. Journal of Medicinal Chemistry. 27(5). 664–670. 15 indexed citations

Schabel, F. M., Daniel P. Griswold, Thomas H. Corbett, & W R Laster. (1983). Increasing therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology. Pharmacology & Therapeutics. 20(2). 283–305. 39 indexed citations

Schabel, F. M., Howard E. Skipper, M W Trader, et al.. (1982). Drug control of Ara-C-resistant tumor cells. Medical and Pediatric Oncology. 10(S1). 125–148. 17 indexed citations

Struck, Robert F., Donald J. Dykes, W R Laster, & Jane Montgomery. (1980). Isophosphoramide mustard (ipm), a non-urotoxic metabolite of the clinical antitumor agent ifosfamide (ifa) with activity against murine tumors comparable to cyclophosphamide (cpa). Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 290. 1 indexed citations

Smith, Harold P., Dixon M. Moody, Marshall R. Ball, et al.. (1979). The Trapped Temporal Horn. Neurosurgery. 5(2). 245–249. 12 indexed citations

10.

Schabel, F. M., M W Trader, & W R Laster. (1979). CISDIAMMINE DICHLOROPLATINUM II AOMBINATION CHEMOTHERAPY AND CROSS-RESISTANCE STUDIES WITH TUMORS OF MICE. 63. 1459–1473.

11.

Montgomery, John A., G. S. MCCALEB, Thomas P. Johnston, Joseph G. Mayo, & W R Laster. (1977). Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma. Journal of Medicinal Chemistry. 20(2). 291–295. 10 indexed citations

12.

Farman, Jack, et al.. (1976). Bronchogenic cysts involving esophagus.. PubMed. 76(9). 1507–11. 1 indexed citations

13.

Bennett, L. Lee, et al.. (1973). Studies with 8-azainosine, a cytotoxic nucleoside with antitumor activity.. PubMed. 33(3). 465–71. 16 indexed citations

14.

Johnston, Thomas P., et al.. (1971). Synthesis of potential anticancer agents. 38. N-nitrosoureas. 4. Further synthesis and evaluation of haloethyl derivatives. Journal of Medicinal Chemistry. 14(7). 600–614. 27 indexed citations

15.

Shealy, Y. Fulmer, et al.. (1971). Triazenes of Phenylbutyric, Hydrocinnamic, Phenoxyacetic, and Benzoylglutamic Acid Derivatives. Journal of Pharmaceutical Sciences. 60(8). 1192–1198. 3 indexed citations

16.

Schabel, F. M., W R Laster, & M W Trader. (1968). Therapeutic potentiation of antileukemic drugs. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 62. 1 indexed citations

17.

Griswold, Daniel P., Howard E. Skipper, W R Laster, W. S. Wilcox, & F. M. Schabel. (1966). Induced mammary carcinoma in the female rat as a drug evaluation system.. PubMed. 26(10). 2169–80. 39 indexed citations

18.

Griswold, Daniel P., et al.. (1963). Experimental Evaluation of Potential Anticancer Agents: XII. Quantitative Drug Response of the SA180, CA755, and Leukemia L1210 Systems to a “Standard List” of “Active” and “Inactive” Agents. Cancer Research. 23. 271–519. 10 indexed citations

19.

Laster, W R, et al.. (1961). Experimental evaluation of potential anticancer agents. IV. Host weight loss as it relates to false positives in drug evaluation.. PubMed. 21. 895–906. 8 indexed citations

20.

Casey, A. E., W R Laster, & Gary Ross. (1951). Sustained Enhanced Growth of Carcinoma EO771 in C57 Black Mice. Experimental Biology and Medicine. 77(2). 358–362. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact